Pharmacydude, Excellent Post! (A concept that JL used to educate us about
seemingly a decade ago.) This in a major reason I used to believe that
a BO of AMRN by BP was in the cards. (I assumed that BP understood this
concept.) My belief remains in the Concept of health benefits from EPA,
not only in fighting CVD, but Cancer as well if used as an adjunct
therapy. Of course, Alzheimer's Disease seems like a "no-brainer."
(Yes, a terrible pun, I know.)
Of course, so far AMRN's BOD and management has seemed incapable of
getting either the drug or information about its prospects to gain
much in the way of traction or interest. Maybe the only way that
changes is with a BP BO which we now hope that Dr. Denner will
facilitate despite our "world-class" management & BOD. Someday,
someone will figure out that Vascepa is an excellent "adjunct therapy"
medication for Cancer. (What would be the harm of any study for a
Cancer drug/therapy adding a Vascepa arm to the study?) Maddening
to think about all this...Then again we live a world seemingly
controlled by "irrational actors" these days.